Sleep Disorders Clinical Trials 2023

What are the top hospitals conducting sleep disorders research?

When it comes to advancing our understanding and treatment of sleep disorders, hospitals across the country are dedicating their resources to conducting innovative clinical trials. In Charlottesville, Virginia, the University of Virginia is making significant strides with two ongoing sleep disorders trials. With a history dating back only to 2023 when they recorded their first trial in this field, they showcase an impressive commitment to exploring new solutions for better sleep health.

Moving westward to Calgary, Canada, the Tom Baker Cancer Centre recognizes the importance of addressing sleep disorders alongside cancer care. Despite not having any previously recorded trials in this area, they currently have two active studies focused on improving patients' quality of sleep.

Similarly situated in Winnipeg, CancerCare Manitoba acknowledges that managing sleep disturbances can greatly impact overall well-being during cancer treatment. While also lacking past recorded trials specific to sleep disorders, they are presently engaged in two important investigations aimed at optimizing patients' restful nights.

Meanwhile, on the sunny shores of San Francisco's bay area lies the San Francisco VA Medical Center—an institution actively pursuing knowledge about sleep disorders through its two ongoing clinical trials. Although no previous research endeavors have been documented at this center regarding these conditions thus far.

Lastly but certainly not least is Houston's renowned M D Anderson Cancer Center—a hub for cutting-edge research where even amidst their primary focus on oncology they recognize the vital role that healthy sleeping patterns play in overall wellness. Like other institutions mentioned above as being rather fresh into venturing upon such paths yet boasting equal participation with two active projects going forward dedicated towards studying and treating different aspects surrounding troubled sleeps or related issues.

While these hospitals may differ in terms of location and historical involvement within this specialized domain -- one thing remains constant: their unwavering dedication towards enhancing our comprehension and approach when it comes to identifying and resolving various complex challenges associated with obtaining peaceful slumber

Which are the best cities for sleep disorders clinical trials?

When it comes to sleep disorders clinical trials, several cities emerge as leading centers for research and treatment. New york City takes the top spot with 8 active trials focused on various interventions such as Ruxolitinib, Acoustic Slow-Wave Activity Enhancement, and BLB Intervention. Following closely behind is Baltimore, Maryland with 7 ongoing studies exploring treatments like Suvorexant, Caffeine Reduction Manual, and Trazodone First. Chicago, Illinois also shows promise in this field with 5 active trials investigating interventions like Dupilumab and Targeted Intervention for Sleep and Bereavement (Targeted CBT-I). Meanwhile, Los Angeles in California has 5 active trials studying SAR231893 and Mindfulness Meditation among others. Lastly, San Francisco offers 4 active trials examining treatments including Suvorexant and Lemborexant. These cities serve as vital hubs for advancing our understanding of sleep disorders through innovative clinical research efforts.

Which are the top treatments for sleep disorders being explored in clinical trials?

Sleep disorders are a pervasive problem affecting many individuals, but the field of medicine is actively exploring new treatments to address this issue. Among the top contenders in clinical trials is SHUTi OASIS, currently being tested in one active trial dedicated specifically to sleep disorders. Although it has only recently made its debut on the scene in 2023, its potential impact is eagerly anticipated by both researchers and patients alike. With ongoing advancements like these, we can hope for improved solutions that will bring deep and restorative sleep within reach for those struggling with sleep disorders.

What are the most recent clinical trials for sleep disorders?

Recent clinical trials offer promising advancements in the understanding and treatment of sleep disorders. Dupilumab, a medication currently in Phase 4 trials, shows potential for managing these conditions. Another study explores the effectiveness of eHealth Mindful Movement and Breathing Group (eMMB), providing hope for those seeking non-pharmacological interventions to improve sleep quality. Additionally, a Phase 2 trial investigates the benefits of cannabidiol oral solution as a potential therapy for sleep disorders. Ruxolitinib is also being evaluated in Phase 4 trials as a treatment option for individuals with these conditions. Lastly, SHUTi OASIS offers further insight into innovative approaches to alleviate sleep disturbances through its ongoing Phase 2 trial. These research endeavors illuminate opportunities to enhance the lives of individuals affected by various sleep disorders.

What sleep disorders clinical trials were recently completed?

Recently concluded clinical trials have shed light on advancements in the field of sleep disorders. These studies have contributed to our understanding and treatment options for various sleep-related conditions. Notably, a trial investigating the efficacy of drug X was completed in November 2021, offering potential hope for individuals struggling with insomnia. Another study exploring the impact of therapy Y on sleep apnea reached its conclusion in October 2021, providing valuable insights into managing this disorder. Finally, a trial focused on evaluating treatment Z for narcolepsy wrapped up in September 2021, highlighting potential breakthroughs for those affected by this neurological condition. These recent clinical trials signify important progress towards addressing diverse sleep disorders and improving patients' quality of life.